Q1/2020 3/31/2020 EPS 1.010 ZacksConsensus 0.820 ActVsEst 0.190 - Beat
West Pharmaceutical Services, Inc. (WST)
Last west pharmaceutical services, inc. earnings: 4/23 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.westpharma.com
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
WST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WST alerts
High impacting West Pharmaceutical Services, Inc. news events
Weekly update
A roundup of the hottest topics
WST
News
- Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at Bank of America Co. from $350.00 to $355.00. They now have a "buy" rating on the stock.MarketBeat
- West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.MarketBeat
- West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $390.00 price target on the stock, up previously from $350.00.MarketBeat
- West Elects New Director to the BoardPR Newswire
WST
Earnings
- 10/24/24 - Beat
WST
Sec Filings
- 12/18/24 - Form 3
- 12/18/24 - Form 4
- 12/13/24 - Form 8-K
- WST's page on the SEC website